<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Carnitine palmitoyltransferase 1C regulates cancer cell senescence through 
mitochondria-associated metabolic reprograming.

Cellular senescence is a fundamental biological process that has profound 
implications in cancer development and therapeutics, but the underlying 
mechanisms remain elusive. Here we show that carnitine palmitoyltransferase 1C 
(CPT1C), an enzyme that catalyzes carnitinylation of fatty acids for transport 
into mitochondria for Î²-oxidation, plays a major role in the regulation of 
cancer cell senescence through mitochondria-associated metabolic reprograming. 
Metabolomics analysis suggested alterations in mitochondria activity, as 
revealed by the marked decrease in acylcarnitines in senescent human pancreatic 
carcinoma PANC-1 cells, indicating low CPT1C activity. Direct analyses of mRNA 
and protein show that CPT1C is significantly reduced in senescent cells. 
Furthermore, abnormal mitochondrial function was observed in senescent PANC-1 
cells, leading to lower cell survival under metabolic stress and suppressed 
tumorigenesis in a mouse xenograft model. Knock-down of CPT1C in PANC-1 cells 
induced mitochondrial dysfunction, caused senescence-like growth suppression and 
cellular senescence, suppressed cell survival under metabolic stress, and 
inhibited tumorigenesis in vivo. Further, CPT1C knock-down suppressed xenograft 
tumor growth in situ. Silencing of CPT1C in five other tumor cell lines also 
caused cellular senescence. On the contrary, gain-of-function of CPT1C reversed 
PANC-1 cell senescence and enhanced mitochondrial function. This study 
identifies CPT1C as a novel biomarker and key regulator of cancer cell 
senescence through mitochondria-associated metabolic reprograming, and suggests 
that inhibition of CPT1C may represent a new therapeutic strategy for cancer 
treatment through induction of tumor senescence.
]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="1096~1115" text="Knock-down of CPT1C" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P1" spans="1332~1348" text="CPT1C knock-down" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P2" spans="1393~1411" text="Silencing of CPT1C" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P3" spans="1494~1519" text="gain-of-function of CPT1C" perturbingaction="gene gain-of-function" />
<CONTEXT id="C0" spans="1073~1094" text="mouse xenograft model" context="xenograft" />
<CONTEXT id="C1" spans="1119~1131" text="PANC-1 cells" context="cells" />
<CONTEXT id="C2" spans="1314~1321" text="in vivo" context="in vivo" />
<CONTEXT id="C3" spans="1360~1369" text="xenograft" context="xenograft" />
<CONTEXT id="C4" spans="1426~1442" text="tumor cell lines" context="transformed cells" />
<CONTEXT id="C5" spans="1530~1541" text="PANC-1 cell" context="transformed cells" />
<PHENOTYPE id="PH0" spans="1054~1067" text="tumorigenesis" phenotype="tumourigenesis" />
<PHENOTYPE id="PH1" spans="1224~1234" text="senescence" phenotype="senescence" />
<PHENOTYPE id="PH2" spans="1247~1260" text="cell survival" phenotype="cell survival" />
<PHENOTYPE id="PH3" spans="1300~1313" text="tumorigenesis" phenotype="tumourigenesis" />
<PHENOTYPE id="PH4" spans="1371~1383" text="tumor growth" phenotype="tumour growth" />
<PHENOTYPE id="PH5" spans="1465~1475" text="senescence" phenotype="senescence" />
<PHENOTYPE id="PH6" spans="1542~1552" text="senescence" phenotype="senescence" />
<EFFECT id="E0" spans="1042~1052" text="suppressed" effect="negative" />
<EFFECT id="E1" spans="1168~1174" text="caused" effect="positive" />
<EFFECT id="E2" spans="1236~1246" text="suppressed" effect="negative" />
<EFFECT id="E3" spans="1290~1299" text="inhibited" effect="negative" />
<EFFECT id="E4" spans="1349~1359" text="suppressed" effect="negative" />
<EFFECT id="E5" spans="1449~1455" text="caused" effect="positive" />
<EFFECT id="E6" spans="1520~1528" text="reversed" effect="negative" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P0" perturbing_actionText="Knock-down of CPT1C" contextID="C1" contextText="PANC-1 cells" effectID="E1" effectText="caused" phenotypeID="PH1" phenotypeText="senescence" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P0" perturbing_actionText="Knock-down of CPT1C" contextID="C1" contextText="PANC-1 cells" effectID="E2" effectText="suppressed" phenotypeID="PH2" phenotypeText="cell survival" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P0" perturbing_actionText="Knock-down of CPT1C" contextID="C1" contextText="PANC-1 cells" effectID="E3" effectText="inhibited" phenotypeID="PH3" phenotypeText="tumorigenesis" />
<ENTITY_LINKING id="EN3" perturbing_actionID="P0" perturbing_actionText="Knock-down of CPT1C" effectID="E3" effectText="inhibited" phenotypeID="PH3" phenotypeText="tumorigenesis" contextID="C2" contextText="in vivo" />
<ENTITY_LINKING id="EN4" perturbing_actionID="P1" perturbing_actionText="CPT1C knock-down" effectID="E4" effectText="suppressed" contextID="C3" contextText="xenograft" phenotypeID="PH4" phenotypeText="tumor growth" />
<ENTITY_LINKING id="EN5" perturbing_actionID="P2" perturbing_actionText="Silencing of CPT1C" contextID="C4" contextText="tumor cell lines" effectID="E5" effectText="caused" phenotypeID="PH5" phenotypeText="senescence" />
<ENTITY_LINKING id="EN6" perturbing_actionID="P3" perturbing_actionText="gain-of-function of CPT1C" effectID="E6" effectText="reversed" contextID="C5" contextText="PANC-1 cell" phenotypeID="PH6" phenotypeText="senescence" />
</TAGS>
</Genomics_ConceptTask>